World's Best Scientists 2026 revealed!
Hiroki Yoshida

Hiroki Yoshida

D-Index & Metrics

Immunology

D-Index
61
Citations
25921
World Ranking
3181
National Ranking
132

Hiroki Yoshida publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hiroki Yoshida sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 186 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hiroki Yoshida D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hiroki Yoshida sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hiroki Yoshida is a researcher affiliated with Saga University in Japan. Their work primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in several specialized subfields including Immunology, Infectious Diseases, Surgery, Parasitology, and Molecular Biology.

The scientific topics covered in their research include:

  • Amoebic Infections and Treatments
  • Parasitic Infections and Diagnostics
  • Pediatric Hepatobiliary Diseases and Treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • Mycobacterium Research and Diagnosis

Yoshida has contributed to multiple peer-reviewed articles, with several recent papers published in respected journals. Some of these include:

  • "TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation," 2021, Nature Communications
  • "Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin," 2021, Science Immunology
  • "The dynamics of ultrastructural changes during Entamoeba invadens encystation," 2020, Parasitology
  • "Adjuvant activity of Mycobacteria-derived mycolic acids," 2020, Heliyon
  • "CD47 promotes peripheral T cell survival by preventing dendritic cell-mediated T cell necroptosis," 2023, Proceedings of the National Academy of Sciences

The research collaborations of Hiroki Yoshida include frequent co-authors such as:

  • Fumika Mi-ichi
  • Hiromitsu Hara
  • Hiroshi Tsugawa
  • Makoto Arita
  • Ei'ichi Iizasa

The main venues in which Yoshida publishes include:

  • mSphere
  • Japanese Journal of JSCE
  • Heliyon
  • Polymers
  • Marine Engineering

Best Publications

  • OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

    Young-Yun Kong;Hiroki Yoshida;Ildiko Sarosi;Hong-Lin Tan

  • Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

    Hiroshi Takayanagi;Sunhwa Kim;Takako Koga;Takako Koga;Hiroshi Nishina

  • Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death

    Nicholas Joza;Nicholas Joza;Santos A. Susin;Eric Daugas;William L. Stanford

  • Apaf1 is required for mitochondrial pathways of apoptosis and brain development.

    Hiroki Yoshida;Hiroki Yoshida;Young-Yun Kong;Young-Yun Kong;Ritsuko Yoshida;Ritsuko Yoshida;Andrew J Elia;Andrew J Elia

  • Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.

    Masataka Asagiri;Kojiro Sato;Takako Usami;Sae Ochi

  • SOCS1/JAB is a negative regulator of LPS-induced macrophage activation

    Ichiko Kinjyo;Toshikatsu Hanada;Kyoko Inagaki-Ohara;Hiroyuki Mori

  • Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment

    Atsunobu Takeda;Shinjiro Hamano;Atsushi Yamanaka;Toshikatsu Hanada

  • Anti-interleukin-31 receptor a antibody for atopic dermatitis

    Thomas Ruzicka;Jon M. Hanifin;Masutaka Furue;Grazyna Pulka

  • The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection

    Alejandro Villarino;Linda Hibbert;Linda Lieberman;Emma Wilson

  • The immunobiology of interleukin-27.

    Hiroki Yoshida;Christopher A. Hunter

  • The Transcription Factor NF-ATc1 Regulates Lymphocyte Proliferation and Th2 Cytokine Production

    Hiroki Yoshida;Hiroshi Nishina;Hiroshi Nishina;Hiroaki Takimoto;Hiroaki Takimoto;Luc E.M Marengère;Luc E.M Marengère

  • The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.

    Hiromitsu Hara;Chitose Ishihara;Arata Takeuchi;Takayuki Imanishi

  • Probiotic Bifidobacterium breve Induces IL-10-Producing Tr1 Cells in the Colon

    Seong Gyu Jeon;Hisako Kayama;Yoshiyasu Ueda;Takuya Takahashi

  • Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.

    Takeru Yoshimura;Koh Hei Sonoda;Mika Sugahara;Yasutaka Mochizuki

  • WSX-1 Is Required for Resistance to Trypanosoma cruzi Infection by Regulation of Proinflammatory Cytokine Production

    Shinjiro Hamano;Kunisuke Himeno;Yoshiyuki Miyazaki;Yoshiyuki Miyazaki;Kazunari Ishii

  • Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production Including IL-23-Induced IL-17 on Activated CD4+ T Cells Partially Through STAT3-Dependent Mechanism

    Takeru Yoshimura;Atsunobu Takeda;Shinjiro Hamano;Yoshiyuki Miyazaki

  • The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis

    Christoph Hölscher;Alexandra Hölscher;Dominik Rückerl;Takayuki Yoshimoto

  • Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity

    Toshikatsu Hanada;Hiroki Yoshida;Seiya Kato;Kentaro Tanaka

  • The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity

    David Artis;Alejandro Villarino;Michael Silverman;Weimian He

  • The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells

    Toshiaki Ohteki;Hiroki Yoshida;Toshifumi Matsuyama;Gordon S. Duncan

  • Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis

    Takeru Yoshimura;Koh Hei Sonoda;Nobuyuki Ohguro;Yoshiyuki Ohsugi

  • ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1

    Hiroshi Shiraishi;Hideaki Okamoto;Akihiko Yoshimura;Hiroki Yoshida

  • Machinery of programmed cell death

    Hiroki Yoshida

Frequent Co-Authors

Kikuo Nomoto
Kikuo Nomoto Kyushu University
Akihiko Yoshimura
Akihiko Yoshimura Keio University
Tatsuro Ishibashi
Tatsuro Ishibashi Kyushu University
Yoichiro Iwakura
Yoichiro Iwakura Tokyo University of Science
Tak W. Mak
Tak W. Mak Princess Margaret Cancer Centre
Masayuki Miura
Masayuki Miura University of Tokyo
Sho Yamasaki
Sho Yamasaki Osaka University
Masutaka Furue
Masutaka Furue Kyushu University
Andrew Wakeham
Andrew Wakeham Princess Margaret Cancer Centre
Atsushi Hirao
Atsushi Hirao Kanazawa University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology, exploring related online degrees can open numerous opportunities. Many aspiring healthcare professionals turn to programs like the nurse practitioner accelerated program to fast-track their education while gaining specialized clinical skills.

Individuals without a nursing background can also benefit from online accelerated nursing programs for non nurses. These programs provide a streamlined pathway to obtain nursing credentials, making it easier to enter healthcare professions that intersect with immunology research and patient care.

When selecting nursing programs, some students prioritize accessibility. Programs like absn programs with high acceptance rates offer more inclusive admissions criteria, helping more candidates earn their Bachelor of Science in Nursing quickly.

For those starting at the foundational level, admissions-friendly options like easy admission lpn programs provide an approachable entry point into patient care roles that support immunology-focused healthcare environments.

Best Scientists Citing Hiroki Yoshida

Trending Scientists

Recently Published Articles